Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 20 de 319
Article in Chinese | WPRIM | ID: wpr-928261


OBJECTIVE@#To explore clinical effect of arthroscopic debridement combined with platelet-rich plasma (PRP) injection for Kellgren-Lawrence(K-L) gradeⅠ-Ⅲ knee osteoarthritis (KOA) .@*METHODS@#Totally 117 patients with KOA who underwent arthroscopic debridement combined with injection from November 2015 to January 2019 were retrospectively analyzed. According to different injection drugs, the patients were divided into sodium hyaluronate group(group A) and PRP group(group B). In group A, there were 60 patients, including 27 males and 33 females, aged from 49 to 67 years old with an average age of (54.1±4.8) years old;12 patients with gradeⅠ, 23 patients with gradeⅡand 25 patients with grade Ⅲ according to K-L clssification, 2 ml(20 g) sodium hyaluronate was injected into knee joint after intraoperative, 1, 2, 3 weeks after operation for 4 times. In group B, there were 57 patients, including 25 males and 32 females, aged from 47 to 70 years old with an average of (55.8±5.0) years old, 10 patients with gradeⅠ, 20 patients with gradeⅡand 27 patients with grade Ⅲ according to K-L classification, injected 5 ml PRP at the same time. Postoperative complications was recorded between two groups. Postoperative visual analogue scale(VAS) and Lysholm score at 3, 6, 12 months were used to evaluate improvement of knee pain and joint function.@*RESULTS@#All patients were followed up for 12 to 19 months with an average of (14.1±1.6) months. There was no significant difference in postopertaive complications between group A and group B (P>0.05). Postoperative VAS score in group A at 3, 6, 12 months were 3.0±0.8, 2.0±0.8, 2.6±0.9 respectively, and 2.9±0.8, 1.9±0.7, 2.2±0.8 in group B respectively; and no differnece at 3 and 6 months after operation between two groups (P<0.05), while VAS score in group B was higher than group A at 12 months after operation(P<0.05). Postoperative Lysholm score in group A at 1, 6, 12 months (86.6±1.8, 93.1±2.0, 86.7±1.7) were lower than group B(88.9±1.9, 95.0±2.0, 89.0±1.9)(P<0.05).@*CONCLUSION@#Arthroscopic debridement combined with sodium hyaluronate or PRP injection for K-L gradeⅠ-Ⅲ KOA could effectively relieve pain and improve joint function with higher safety in short term, but the medium-long-term effect of PRP injection is stable.

Aged , Debridement , Female , Humans , Injections, Intra-Articular , Male , Middle Aged , Osteoarthritis, Knee/surgery , Platelet-Rich Plasma , Retrospective Studies , Treatment Outcome
Rev. cuba. estomatol ; 58(2): e3053, 2021. graf
Article in Spanish | LILACS, CUMED | ID: biblio-1289405


Introducción: Los desórdenes temporomandibulares son un grupo de trastornos que afectan la articulación temporomandibular y/o los tejidos musculoesqueléticos asociados. Objetivo: Determinar la efectividad de los concentrados de plaquetas en el tratamiento de los desórdenes temporomandibulares. Métodos: La búsqueda de la literatura fue realizada desde enero del 2014 hasta abril del 2019, en las bases de datos biomédicas: PubMed, Embase, SciELO, Scopus, Science Direct, Sistema de información sobre literatura gris en Europa, Literatura Latinoamericana y del Caribe en Ciencias de la Salud, Google Académico y el Registro Central de Ensayos Clínicos Cochrane. Se definieron como criterios de selección de los estudios que fueran ensayos clínicos aleatorizados, con una antigüedad máxima de cinco años, que reportarann la efectividad (reducción del dolor y aumento de apertura máxima) de los concentrados plaquetarios en el tratamiento de los desórdenes temporomandibulares. El riesgo de sesgo de los estudios fue analizado por medio del Manual Cochrane de revisiones sistemáticas de intervenciones. Resultados: La estrategia de búsqueda resultó en nueve artículos, de los cuales el 100 por ciento reportó que no había diferencia en la reducción del dolor y el aumento de apertura máxima de los concentrados plaquetarios en el tratamiento de los desórdenes temporomandibulares. Conclusiones: La literatura revisada sugiere que existe una ligera evidencia de los beneficios potenciales de las inyecciones intraarticulares de los concentrados plaquetarios en pacientes con desórdenes temporomandibulares. Sin embargo, es necesario establecer un protocolo estandarizado para la preparación y aplicación de estos concentrados(AU)

Introduction: Temporomandibular disorders are a group of dysfunctions which affect the temporomandibular joint and/or associated musculoskeletal tissues. Objective: Determine the effectiveness of platelet concentrates in the treatment of temporomandibular disorders. Methods: A bibliographic search was conducted from January 2014 to April 2019 in the biomedical databases PubMed, Embase, SciELO, Scopus, Science Direct, System for Information on Gray Literature in Europe, Latin American and Caribbean Health Sciences Literature, Google Scholar, and Cochrane Central Register of Clinical Trials. The following selection criteria were defined for the studies: randomized clinical trials published in the last five years and reporting on the effectiveness (pain reduction and maximum opening increase) of platelet concentrates in the treatment of temporomandibular disorders. Bias risk analysis was based on the Cochrane manual of systematic reviews of interventions. Results: Nine papers were retrieved, of which 100 percent reported no differences in pain reduction or maximum opening increase resulting from the use of platelet concentrates in the treatment of temporomandibular disorders. Conclusions: The literature review conducted suggests that there is slight evidence of the potential benefits of intra-articular injections of platelet concentrates in patients with temporomandibular disorders. However, a standardized protocol should be established for the preparation and application of these concentrates(AU)

Humans , Temporomandibular Joint Disorders/therapy , Platelet-Rich Fibrin , Injections, Intra-Articular/methods , Review Literature as Topic , Databases, Bibliographic
Article in Chinese | WPRIM | ID: wpr-879456


OBJECTIVE@#To compare clinical effects of compound betamethasone and compound betamethasone with hyaluronic acid in treating moderate-severe knee osteoarthritis (KOA).@*METHODS@#A prospective randomized controlled study was conducted in 116 patients with unilateral moderate-severe KOA patients from February 2017 to November 2017 and divided into observation group and control group, 58 patients in each group. In observation group, there were 15 males and 43 females aged from 45 to 80 years old with an average of (66.45±6.31) years old;according to Kellgren-Lawrence(K-L) classification, 42 patients were type Ⅲ and 16 patients were type Ⅳ;the courses of disease ranged from 4 to 8 years with an average of (5.25±2.21) years;the patients were treated by injecting 1 ml compound betamethasone into knee joint. In control group, there were 13 males and 45 females aged from 45 to 80 years old with an average of (64.89±6.41) years old;according to K-L classification, 43 patients were type Ⅲ and 15 patients were type Ⅳ;the courses of disease ranged from 4 to 10 years with an average of (5.41±2.35) years;the patients were treated by knee joint injection of 4 ml hyaluronic acid and 1 ml compound betamethasone. Visual analog scale (VAS), Western Ontario and McMaster University Osteoarthritis Index (WOMAC) were used to evaluate clinical effects before treatment and 1 week, 1, month, 3 and 6 months after treatment.@*RESULTS@#Totally 55 patients in observation group were followed up for 6 months, and 3 patients were quit at 3 months after treatment for poor efficacy. Totally 56 patients in control group were followed up for 6 months, and 2 patients were withdrew from the follow-up on the first and third month respectively for poor efficacy. There were no statistical difference in VAS and WOMAC between two groups before treatment and different time points after treatment (@*CONCLUSION@#For patients with moderate-severe KOA, there is no significant difference in therapeutic effect between compound betamethasone injection and compound betamethasone combined with hyaluronic acid injection, and long-term effect of two methods is not good.

Betamethasone , Child , Child, Preschool , Female , Humans , Hyaluronic Acid , Injections, Intra-Articular , Male , Osteoarthritis, Knee/drug therapy , Prospective Studies , Treatment Outcome
Rev. méd. Maule ; 36(2): 34-43, dic. 2020. ilus
Article in Spanish | LILACS | ID: biblio-1344612


Pain located in the lateral aspect of the elbow is a common cause of consultation in the trauma consultation. The most common cause is "lateral epicondylitis," however there are several differential diagnoses that may require different management. There is a case of radial tunnel syndrome secondary to extrinsic compression, with an emphasis on its diagnosis and surgical technique.

Humans , Male , Middle Aged , Carpal Tunnel Syndrome/diagnosis , Radial Neuropathy/surgery , Radial Neuropathy/diagnosis , Nerve Compression Syndromes , Radial Nerve , Synovial Cyst/surgery , Magnetic Resonance Imaging , Combined Modality Therapy , Elbow , Elbow Joint , Pain Management , Injections, Intra-Articular , Neurologic Examination/methods
Rev. bras. anestesiol ; 70(4): 318-324, July-Aug. 2020. tab, graf
Article in English, Portuguese | LILACS | ID: biblio-1137199


Abstract Introduction: Tranexamic Acid (TXA), an antifibrinolytic that inhibits the fibrinolytic activity of plasmin is used to decrease perioperative blood loss and transfusion requirements in orthopedic surgery. The aim of our study was to compare postoperative bleeding in two intra-articular doses (1 g and 2 g) of tranexamic acid in adult patients undergoing unilateral total knee replacement. Method: We conducted a single-operator, randomized, and controlled, double-blind study in two groups. The G1 group received 1 g of intra-articular TXA and the G2 group 2 g of intra-articular TXA. Both groups received 15 mg kg-1 IV before the surgical incision (TXA induction dose) and then 10 mg kg-1, orally, 6 and 12 hours after the induction dose of TXA.The primary endpoint was bleeding measured by blood loss in postoperative drainage. Secondary outcomes were change in hemoglobin and hematocrit levels on the first and third postoperative days, and the need for transfusion during hospitalization. Results: In total, 100 patients were randomized, and 100 were included in the analysis. Blood loss in postoperative drainage was similar in both groups (200 ± 50 vs. 250 ± 50 mL, G1 and G2 groups respectively). Change in hematocrit and hemoglobin values (% of change) between preoperative and day 3 were not statically significant between groups G1 and G2 (18 ± 5 vs. 21 ± 4; 21 ± 7 vs. 22 ± 5 respectively). No patients received blood transfusion. Conclusions: Our study did not show superiority of 2 g of intra-articular tranexamic acid compared to 1 Identifier NCT04085575

Resumo Introdução: O Ácido Tranexâmico (TXA), agente antifibrinolítico que inibe a atividade fibrinolítica da plasmina, é usado para reduzir a perda sanguínea perioperatória e a necessidade de transfusão em cirurgia ortopédica. O objetivo do estudo foi comparar o efeito de duas doses intra-articulares (1 g e 2 g) de ácido tranexâmico no sangramento pós-operatório de pacientes adultos submetidos a prótese total unilateral de joelho. Método: Realizamos estudo com operador único, randomizado, controlado e duplo-cego em dois grupos. O grupo G1 recebeu 1 g de TXA intra-articular e o grupo G2, 2 g de TXA intra-articular. Os dois grupos receberam 15 IV antes da incisão cirúrgica (dose de indução de TXA) e 10 por via oral, 6 e 12 horas após a dose de indução de TXA. O desfecho primário foi o sangramento medido pela perda sanguínea na drenagem pós-operatória. Os desfechos secundários foram alteração nos níveis de hemoglobina e hematócrito no primeiro e terceiro dias de pós-operatório e necessidade de transfusão durante a hospitalização. Resultados: Cem pacientes foram randomizados e 100 foram incluídos na análise. A perda sanguínea pela drenagem pós-operatória foi semelhante nos dois grupos (200 ± 50 mL vs. 250 ± 50 mL, grupos G1 e G2, respectivamente). A variação nos valores de hematócrito e hemoglobina (% de variação) entre o pré-operatório e o dia 3 não foi estatisticamente significante entre os grupos G1 e G2 (18 ± 5 vs. 21 ± 4; 21 ± 7 vs. 22 ± 5, respectivamente). Nenhum paciente recebeu transfusão de sangue. Conclusões: O estudo não mostrou superioridade na dose de 2 g de ácido tranexâmico intra-articular em comparação à dose de 1 g. Identifier NCT04085575.

Humans , Male , Female , Aged , Tranexamic Acid/administration & dosage , Postoperative Hemorrhage/prevention & control , Arthroplasty, Replacement, Knee/methods , Antifibrinolytic Agents/administration & dosage , Hemoglobins/metabolism , Double-Blind Method , Hematocrit , Injections, Intra-Articular
Article in Chinese | WPRIM | ID: wpr-879354


OBJECTIVE@#To investigate the effect of intra-articular injection of tranexamic acid on blood loss and blood transfusion rate after minimally invasive unicompartmental knee arthroplasty.@*METHODS@#From January 2015 to September 2017, 90 patients underwent minimally invasive unicompartmental knee arthroplasty were divided into tranexamic acid group and control group, 45 cases in each group. In the tranexamic acid group, there were 22 males and 23 females, aged 62 to 69 (66.1±2.4) years;in the control group, 20 males and 25 females, aged 63 to 71(68.5±5.2) years. The amount of bleeding in the drainage ball at 48 hours after operation was recorded, and the blood transfusion rate and hematocrit level duringthe perioperative period were recorded. The factors influencing perioperative blood loss included gender, age and body mass index (BMI).@*RESULTS@#All patients were followed up for 12.5 to 28.3 (22.8±7.9) months. During the follow-up, the wounds of the two groups healed well, and no deep vein thrombosis and pulmonary embolism occurred. There was no significant difference in postoperative blood loss between the tranexamic acid group and the control group. The postoperative bleeding volume in the tranexamic acid group was (110.0±52.1) ml, and that in the control group was (123.0±64.5) ml (P=0.39). There was no blood transfusion in the two groups.@*CONCLUSION@#Intra articular injection of tranexamic acid can not significantly reduce the postoperative blood loss in patients with minimally invasive unicompartment.

Aged , Antifibrinolytic Agents/therapeutic use , Arthroplasty, Replacement, Knee/adverse effects , Blood Loss, Surgical/prevention & control , Female , Hemostatics , Humans , Injections, Intra-Articular , Male , Middle Aged , Postoperative Hemorrhage , Tranexamic Acid
Article in English | WPRIM | ID: wpr-827427


OBJECTIVES@#To evaluate the efficacy of different ways of cocktail analgesic mixture injection on total knee arthroplasty (TKA).@*METHODS@#A total of 50 patients with knee osteoarthritis treated by TKA from July to September 2018 were randomly divided into two groups (=25). The Group 1 underwent anterior intra-articular injection before prosthesis implanted while the Group 2 underwent posterior intra-articular injection before prosthesis implanted. Visual Analogue Scale (VAS) of all patients for pain during activity and at rest, maximal flexion degree of the knee at the 48th h and the 72th h after surgery, the time of raise leg, usage rate of patient-controlled analgesia (PCA), and complications were evaluated and analyzed.@*RESULTS@#VAS for pain at rest of patients in the Group 1 was significantly less than that in the Group 2 at the 6th, 12th, and 24th h after surgery (all <0.05). Maximal flexion degree of the knee at the 48th h and the 72th h after surgery in the Group 1 was better than that in the Group 2 (both <0.05). The Group 1 costed less time than the Group 2 on the ability to perform an active straight leg raise (=0.027).@*CONCLUSIONS@#The anterior intra-articular cocktail analgesic mixture injection can strongly relieve the pain early after TKA, which can improve knee function and achieve painless rehabilitation in most patients, with safety.

Analgesics , Arthroplasty, Replacement, Knee , Humans , Injections, Intra-Articular , Osteoarthritis, Knee , General Surgery , Pain Measurement , Pain, Postoperative
Acta ortop. mex ; 33(6): 365-369, nov.-dic. 2019. tab, graf
Article in Spanish | LILACS | ID: biblio-1345062


Resumen: Introducción: La artroscopía de rodilla es uno de los procedimientos que más comúnmente se realizan para tratar esta articulación. La anestesia general y el bloqueo espinal son las modalidades de anestesia más comunes para este procedimiento. Consideramos que esta cirugía se puede manejar con anestesia local intraarticular, con lo que se evitan estancias en recuperación más prolongadas; tiene un mejor manejo efectivo del dolor y optimización de tiempos prequirúrgicos, intraquirúrgicos y postquirúrgicos. Material y métodos: Estudio prospectivo, cuasiexperimental y longitudinal, realizado para comparar dos procedimientos anestésicos: la anestesia intraarticular (lidocaína con epinefrina, bupivacaína y fentanil) sin uso de isquemia (grupo A) y el bloqueo espinal y uso de manguito de isquemia (grupo B). Ambos procedimientos se calcularon mediante la evaluación de la edad, el tiempo de cirugía, el dolor transquirúrgico y a las 24 horas mediante escala EVA, el tiempo de estancia en recuperación, la necesidad de administrar anestesia general o dosis anestésica de rescate y los grados de flexión a las 24 horas en el postquirúrgico. Se utilizó prueba t de Student con un nivel de significación p < 0.05 para variables no paramétricas y χ2 para variables paramétricas. Resultados: Se incluyeron 38 pacientes por cada grupo. El tiempo quirúrgico fue de 45 contra 39 minutos (p = 0.03); el tiempo en recuperación: 1.9 contra 3 horas (p = 0.0004), el cual fue menor en el grupo A, mientras que el dolor transquirúrgico fue mayor (17 contra 3% [p = 0.09]), sin requerir anestesia general. Conclusiones: Las ventajas a favor de la anestesia intraarticular fueron: estadías hospitalarias cortas, menor dolor a las 24 horas y seguridad en su aplicación. Su desventaja es la probabilidad de dolor transquirúrgico, siendo suficiente la sedación.

Abstract: Indroduction: Knee arthroscopy is one of the most commonly performed procedures. General anesthesia and spinal blockage are the most common forms of anesthesia. We consider that this surgery can be managed with intra-articular local anesthesia, thus avoiding prolonged stays in recovery, with effective pain management and optimization of presurgical, intrasurgical and post-surgical times. Material and methods: Prospective, quasi-experimental, longitudinal study to compare two anesthetic procedures: intraarticular anesthesia (lidocaine with epinephrine, bupivacaine and fentanyl) without the use of ischemia (group A); spinal blockage and use of ischemia (group B) by assessing age, surgery time, pain during surgery and 24 hour post-op VA scale, time spent in recovery, need to administer general anesthesia or anesthetic rescue doses, 24-hour range of motion. Student t-test, significance level was used: p < 0.05 for nonparametric variables and χ2 parametric variables. Results: 38 patients were included per group. The surgical time (45 min vs 39 min, p = 0.03), recovery time (1.9 vs 3 hours, p = 0.0004) were lower in group A, while pain during surgery was greater (17 vs 3%, p = 0.09), without requiring general anesthesia. Conclusion: The advantages in favor of intraarticular anesthesia were: shortened hospital stays, less pain at 24 hours, safety in its application. Its disadvantage is the possibility of pain during surgery and sedation is sufficient as adjuvant.

Humans , Arthroscopy , Anesthesia, Spinal , Pain, Postoperative , Bupivacaine , Double-Blind Method , Prospective Studies , Injections, Intra-Articular , Anesthesia, Local , Knee Joint , Lidocaine/therapeutic use
Rev. bras. anestesiol ; 69(5): 439-447, Sept.-Oct. 2019. tab, graf
Article in English | LILACS | ID: biblio-1057449


Abstract Background: Intra-articular injections of platelet-rich plasma to treat symptoms of knee osteoarthritis have been successfully used in young patients. However in most of these studies the control and test knees were present in different patients thus incorporating a large amount of bias in the results. Therefore, the present study was designed in which patients with bilateral osteoarthritis knee were included and platelet-rich plasma was administered in one knee and normal saline in another knee of same patient. Methods: 20 patients aged 30-65 years with bilateral osteoarthritis knees (ASA class I and II) of either gender were included in the study. Patients were randomized to receive platelet-rich plasma and normal saline in one of the two knees. The primary outcome was VAS and WOMAC score at 6 months after procedure. The secondary outcome included changes in joint stiffness, physical function, any adverse effects noted during the course of study. Results: The baseline VAS score in platelet-rich plasma knee was 8.4 ± 0.88 which improved significantly to 4.85 ± 2.48 (p < 0.001) at 6 months as compared to normal saline knee (p = 0.017). The WOMAC pain score also improved from baseline (14.5 ± 1.3) to over 6 month 7.00 ± 4.24 (p < 0.001) in platelet-rich plasma knee while in the normal saline knee, no significant change occurred from baseline to six months (10.2 ± 1.2 to 10.05 ± 1.23). There was also significant decrease in stiffness and improvement of physical activity in the platelet-rich plasma knee as compared to normal saline knee. Conclusion: The present study showed significant decrease in pain and stiffness and improvement of physical functions of knee joint with intra-articular platelet-rich plasma injection as compared to normal saline.

Resumo Justificativa e objetivos: Injeções intra-articulares de plasma rico em plaquetas têm sido usadas com sucesso para tratar os sintomas da osteoartrite de joelho em pacientes jovens. Porém, na maioria desses estudos, os joelhos de controle e teste estavam presentes em diferentes pacientes, o que incorporou uma grande quantidade de viés aos resultados. Portanto, o projeto do presente estudo incluiu pacientes com osteoartrite em ambos os joelhos, com a administração de plasma rico em plaquetas em um dos joelhos e de solução salina normal no outro joelho do mesmo paciente. Métodos: 20 pacientes, de ambos os sexos, com idades entre 30-65 anos e portadores de osteoartrite bilateral de joelho (classificação ASA I e II) foram incluídos no estudo. Os pacientes foram randomizados para receber plasma rico em plaquetas e solução salina normal em um dos dois joelhos. O desfecho primário foram os escores VAS e WOMAC seis meses após o procedimento. O desfecho secundário incluiu alterações na rigidez articular, função física e qualquere feito adverso observado durante o curso do estudo. Resultados: O escore VAS basal para o joelho que recebeu plasma rico em plaquetas foi 8,4 ± 0,88 e melhorou significativamente para 4,85 ± 2,48 (p < 0,001) após seis meses, comparado ao joelho que recebeu solução salina normal (p = 0,017). A intensidade da dor avaliada com o WOMAC também melhorou de 14,5 ± 1,3 na fase basal para 7,00 ± 4,24 após seis meses (p < 0,001) nos joelhos que receberam plasma rico em plaquetas, enquanto nenhuma mudança significativa ocorreu nos joelhos que receberam solução salina normal entre a fase basal e após seis meses (10,2 ± 1,2 a 10,05 ± 1,23). Além disso, houve uma diminuição significativa da rigidez e melhora da atividade física nos joelhos que receberam plasma rico em plaquetas, comparados aos joelhos que receberam salina normal. Conclusão: O presente estudo identificou uma diminuição significativa da dor e da rigidez e uma melhora das funções físicas da articulação do joelho com a injeção intra-articular de plasma rico em plaquetas, comparada à solução salina normal.

Humans , Male , Female , Adult , Aged , Arthralgia , Arthralgia/etiology , Osteoarthritis, Knee/complications , Platelet-Rich Plasma , Pain Management/methods , Knee Joint , Double-Blind Method , Treatment Outcome , Injections, Intra-Articular , Middle Aged
Acta ortop. mex ; 33(3): 166-168, may.-jun. 2019.
Article in Spanish | LILACS | ID: biblio-1248656


Resumen: Introducción: La osteoartrosis es actualmente la quinta causa de discapacidad en el adulto. Su prevalencia aumenta a partir de los 40 años. La viscosuplementación es un tratamiento para las etapas iniciales de la osteoartrosis de rodilla. Objetivo: Comparar la eficacia y la calidad de vida en pacientes con gonartrosis sintomática tratados con ácido hialurónico de alto y mediano peso molecular. Material y métodos: Estudio analítico, retrospectivo, transversal, observacional de expedientes clínicos de pacientes con diagnóstico de gonartrosis grado II y grado III, de Octubre de 2017 a Junio de 2018, tratados con viscosuplementación con ácido hialurónico de alto o de mediano peso molecular; se analizó la calidad de vida y la escala de WOMAC de manera previa a la primera aplicación y con seguimiento a los dos, cuatro y seis meses. Resultados: 194 pacientes, con edades entre 30 y 87 años (promedio 61.85; DE = 11.3); 134 mujeres (69.1%) y 60 hombres (30.9%). En ambos grupos la evolución fue hacia la mejoría, con disminución en el puntaje WOMAC, sin diferencia significativa entre grupos. El puntaje de WOMAC tuvo un aumento mínimo pasados seis meses de la aplicación en ambos grupos, lo que se interpreta como disminución del efecto terapéutico. Dos pacientes tuvieron reacciones adversas mínimas localizadas, las cuales se resolvieron con medidas generales. Conclusión: El ácido hialurónico en ambas presentaciones, de alto y de bajo peso molecular, es efectivo en el tratamiento de la gonartrosis sintomática sin diferencia con el peso molecular.

Abstract: Introduction: OA is currently the fifth leading cause of adult disability, its prevalence increases from age 40. Viscosupplementation is a treatment for the early stages of knee OA. Objective: To compare efficacy and quality of life in patients with symptomatic gonartrosis, treated with high and low molecular weight hyaluronic acid. Material and methods: Analytical, retrospective, cross-sectional, observational study of clinical records of patients diagnosed with grade II and grade III gonarthrosis, October 2017 to June 2018, treated with viscosupplementation with high molecular weight hyaluronic acid or low molecular weight; WOMAC quality of life and scale were analyzed prior to the first application and tracked at two, four and six months. Results: 194 patients, aged between 30 to 87 years (promedio 61.85; SD = 11.3); 134 women (69.1%), 60 men (30.9%). In both groups the evolution was towards improvement, with a decrease in the WOMAC score, with no significant difference between groups. The WOMAC score had a minimum increase after 6 months of application in both groups, which is interpreted as decreasing the therapeutic effect. Two patients had localized minimal adverse reactions which were resolved with general measures. Conclusion: Hyaluronic acid in both presentations, high and low molecular weight, are effective in the treatment of symptomatic goonarthrosis without difference to molecular weight.

Humans , Male , Female , Adult , Aged , Aged, 80 and over , Osteoarthritis, Knee/therapy , Viscosupplementation , Quality of Life , Cross-Sectional Studies , Retrospective Studies , Treatment Outcome , Hyaluronic Acid , Injections, Intra-Articular , Middle Aged , Molecular Weight
Rev. Asoc. Argent. Ortop. Traumatol ; 84(2): 122-128, jun. 2019.
Article in Spanish | LILACS, BINACIS | ID: biblio-1003020


Introducción: El acido hialuronico intrarticular se suele utilizar con diferentes esquemas para tratar la artrosis de rodilla. Nuestro objetivo fue analizar la eficacia y el uso del acido hialuronico intrarticular en la practica habitual. Materiales y Métodos: Cohorte retrospectiva observacional. Se evaluo a 1227 pacientes con artrosis de rodilla tratados con acido hialuronico intrarticular 20 mg/2 ml/semana (76%, 20 mg) y 40 mg/2 ml (24%, 40 mg) segun la practica habitual. Seguimiento de 6 meses. Se evaluo la eficacia con la escala de Likert de 5 puntos y la proporcion de respuesta ≥50%. Resultados: La mediana de aplicaciones fue de 5 (20 mg) y 3 (40 mg). El puntaje de Likert mejoro significativamente en ambos grupos a los 6 meses. La mediana del puntaje mejoro de 4 (media 3,77 ± 0,69) al inicio a 2 (media 1,99 ± 0,76) a los 6 meses con 20 mg (p <0,001) y de 4 (media 3,65 ± 0,65) a 2 (media 1,86 ± 0,72) con 40 mg (p <0,001). La proporcion de respuesta ≥50% a los 6 meses fue del 61% y 66%, respectivamente. En el analisis multivariado, la tasa de respuesta ≥50% se asocio con un mayor puntaje inicial, edad mas joven y menor duracion de la enfermedad. Solo un paciente con 20 mg (0,1%) tuvo un episodio adverso serio (artritis septica). Conclusión: Nuestro estudio en la practica clinica comun respalda la efectividad del acido hialuronico intrarticular para tratar la artrosis de rodilla, con un beneficio clinico a los 6 meses de seguimiento. Nivel de Evidencia: IV

Background: Treatment of knee osteoarthritis with intra-articular hyaluronic acid (IA-HA) is frequently used in Argentina, with different dosing forms and injection regimens. Our main objective was to provide real world data on the use and effectiveness of IA-HA. Methods: In this observational retrospective cohort study we studied 1227 patients with knee osteoarthritis treated with IA-HA 20 mg/2 ml weekly (76%-20 mg group) and 40 mg/2 ml (24%-40 mg group) according to standard practice. Follow-up was 6 months and effectiveness was assessed by the 5-point Likert scale and a response of 50% or more. Results: Median number of injections was 5 (20 mg) and 3 (40 mg). Both groups had a significant improvement in the Likert scale from baseline to 6 months. Median score improved from 4 (mean 3.77 ± 0.69) at baseline to a median of 2 (mean 1.99 ± 0.76) at 6 months (20 mg group, p<0.001) and from a median of 4 (mean 3.65 ± 0.65) to a median of 2 (mean 1.86 ± 0.72) in the 40 mg group, p<0.001. The percentages of patients with a response of 50% or more at 6 months were 61% and 66%, respectively. In the multivariate analysis, the 50% response rate was associated with a higher baseline score, younger age and shorter duration of disease. Only one patient in the 20 mg group (0.1%) experienced a serious treatment-related adverse event (septic arthritis) following injection. Conclusion: Our study carried out during routine clinical practice supports the effectiveness of IA-HA for the management of knee osteoarthritis with a clinical advantage observed at a 6-month follow-up. Level of Evidence: IV

Middle Aged , Aged , Argentina , Osteoarthritis, Knee/therapy , Hyaluronic Acid/therapeutic use , Injections, Intra-Articular , Follow-Up Studies
Rev. méd. Chile ; 147(5): 568-573, mayo 2019. tab, graf
Article in Spanish | LILACS | ID: biblio-1014265


Background: In patients with hemophilia, radionuclide synoviorthesis, or the intra-articular injection of a radionuclide to decrease the synovial hypertrophy tissue, aims to decrease or avoid hemarthrosis. Aim: To evaluate the effectiveness of radionuclide synoviorthesis in hemophilia. Material and Methods: Observational retrospective study of the evolution of 107 male patients aged 3 to 54 years who were subjected to radionuclide synoviorthesis between 2007 and 2015. Results: Of 164 treated joints, in 65% treatment was successful, (defined as zero to two hemarthroses and absence of synovitis during the follow up period), in 17% it was partially successful (defined as two or less hemarthroses, but persistence of the synovitis) and failed in 18% of the procedures. No important complications were recorded. Conclusions: Radionuclide synoviorthesis has an overall 82% success rate, is minimally invasive, can be used at any age and is inexpensive We recommend its implementation in Chilean hemophilia treatment centers.

Humans , Male , Child, Preschool , Child , Adolescent , Adult , Middle Aged , Young Adult , Radioisotopes/administration & dosage , Rhenium/therapeutic use , Synovitis/therapy , Yttrium Radioisotopes/therapeutic use , Hemarthrosis/therapy , Hemophilia A/therapy , Synovitis/physiopathology , Synovitis/diagnostic imaging , Time Factors , Reproducibility of Results , Retrospective Studies , Treatment Outcome , Hemarthrosis/physiopathology , Hemarthrosis/diagnostic imaging , Hemophilia A/physiopathology , Injections, Intra-Articular
Rev. bras. anestesiol ; 69(1): 35-41, Jan.-Feb. 2019. tab
Article in English | LILACS | ID: biblio-977411


Abstract Objective: Postoperative pain control is important in terms of early recovery and rehabilitation in arthroscopic meniscectomy. For this purpose, we aimed to compare the effects of intraarticular tramadol, magnesium, and ketamine with combinations of pericapsular bupivacaine on postoperative pain and recovery in arthroscopic meniscectomy. Methods: Ninety patients who underwent arthroscopic meniscectomy were enrolled in the study. Group T was given tramadol, Group K was given ketamine, and Group M was given magnesium reconstituted intraarticularly, and all groups received periarticular bupivacaine. Comparisons were made in terms of the patients' postoperative Visual Analogue Scale scores with and without movement, need for additional analgesics, first analgesic time, mobilization times, adverse effects, and satisfaction with the analgesics. Results: The Visual Analogue Scale scores were lowest in Group T at 0 minutes, and were higher in the 15th and 30th minutes and 1st, 2nd, and 6th hours. Visual Analogue Scale values with movement were found to be high in Group M at 0 and 15 minutes, but they were found to be higher in group T in the 30th minute, 1st, 2nd and 6th hour. The groups were similar in terms of postoperative additional analgesic use, number of analgesic use, and satisfaction with analgesics; however, the first analgesic time was earlier in Group M, and the first mobilization time was earlier in Group K. Conclusion: Intraarticular ketamine enables early mobilization and less need for additional analgesics, it also provides a better analgesic effect in comparison with intraarticular tramadol and magnesium.

Resumo Objetivo: O controle da dor pós-operatória é importante para recuperação e reabilitação precoces em meniscectomia artroscópica. Portanto, nosso objetivo foi comparar os efeitos de tramadol, magnésio e cetamina administrados por via intra-articular em associação com bupivacaína pericapsular sobre a dor e a recuperação após meniscectomia artroscópica. Métodos: Noventa pacientes submetidos à meniscectomia artroscópica foram incluídos no estudo. O Grupo T recebeu tramadol, o Grupo K recebeu cetamina e o Grupo M recebeu magnésio em doses reconstituídas por via intra-articular e todos os grupos receberam bupivacaína por via periarticular. As avaliações foram feitas mediante comparação dos escores em escala visual analógica no pós-operatório dos pacientes em movimento e em repouso, necessidade de analgésicos adicionais, tempo até a primeira necessidade de analgésico, tempo de mobilização, efeitos adversos e satisfação com os analgésicos. Resultados: Os escores da escala visual analógica foram menores no minuto zero e maiores nos minutos 15 e 30 e nas horas 1, 2 e 6 no Grupo T. Os escores da escala visual analógica em movimento foram maiores nos minutos zero e 15 no Grupo M e maiores no minuto 30 e nas horas 1, 2 e 6 no Grupo T. Os escores dos grupos foram semelhantes em relação à necessidade de analgésico adicional no pós-operatório, ao consumo de analgésico e à satisfação com os analgésicos, mas os tempos até a primeira necessidade de analgesia e até a primeira mobilização foram mais curtos nos grupos M e K, respectivamente. Conclusão: A administração intra-articular de cetamina permite mobilização precoce e diminui a necessidade de analgésicos adicionais, além de proporcionar um melhor efeito analgésico em comparação com tramadol e magnésio por via intra-articular.

Humans , Male , Female , Adult , Aged , Pain, Postoperative/drug therapy , Arthroscopy , Tramadol/administration & dosage , Bupivacaine/administration & dosage , Meniscectomy/methods , Analgesics/administration & dosage , Ketamine/administration & dosage , Anesthetics, Local/administration & dosage , Magnesium/administration & dosage , Prospective Studies , Drug Therapy, Combination , Injections, Intra-Articular , Middle Aged
Article in Chinese | WPRIM | ID: wpr-773906


OBJECTIVE@#To observe and evaluate the clinical effect of intra-articular injection of parecoxib in patients with early knee osteoarthritis.@*METHODS@#From September 2016 to August 2017, 107 patients with early knee osteoarthritis were treated, including 50 males and 57 females, aged 45 to 64 (51.9±4.2) years. They were divided into basic therapy+oral glucosamine group(group A) 36 cases, oral celecoxib+basic therapy+oral glucosamine group(group B) 36 cases, intra-articular injection of parecoxib+basic therapy+oral glucosamine group(group C) 35 cases. There was no significant difference in gender, age, BMI and clinical stage(Kellgren-Lawrence classification) between the three groups before treatment. VAS score, HSS score and patient satisfaction were compared before and after treatment in the three groups. The levels of inflammatory cytokines in synovial fluid were measured before and after treatment in the three groups.@*RESULTS@#All cases were followed up for(15.2±2.6) months on average. The VAS score and HSS score of each group were improved after treatment(<0.001). There were significant differences in VAS and HSS scores among the three groups after treatment(<0.001). The clinical efficacy of group C was better than that of group A and B(<0.001), group B was better than that of group A(<0.001), and group C had the highest satisfaction(<0.001). After treatment, the concentration of proinflammatory factor TNF-α and IL-6 in the synovial fluid of each group decreased(<0.001) and the concentration of anti-inflammatory factor IL-10 increased(<0.001). After treatment, the concentrations of TNF-α, IL-6 and IL-10 in the synovial fluid of the three groups were significantly different(<0.001).@*CONCLUSIONS@#For patients with early knee osteoarthritis, intra-articular injection of parecoxib can significantly improve clinical symptoms and avoid adverse reactions of long-term oral NSAIDs, which is an effective treatment.

Adult , Aged , Female , Humans , Injections, Intra-Articular , Isoxazoles , Therapeutic Uses , Male , Middle Aged , Osteoarthritis, Knee , Drug Therapy
Article in Chinese | WPRIM | ID: wpr-773531


OBJECTIVE@#To assess the therapeutic effect of hyaluronate acid (HA) injection through the subpatellar route for treatment of chondromalacia patellae (CP).@*METHODS@#Eighty-eight patients with the diagnosis of CP were enrolled in this prospective study, including 38 with early CP (CP group) and 50 with advanced CP (patellofemoral arthritis group) diagnosed based on image presentations. All the patients received intra-articular HA injections through a subpatellar route once a week for 5 consecutive weeks. The primary outcome measures included WOMAC index scores and Lequesne scores before and at 4, 12, 26 and 52 weeks after the injections. The secondary outcome measures included the 30-m walking time and stair ascending and descending time (one floor) before and at 1, 2, 3, and 4 weeks after the injections.@*RESULTS@#In both groups the patients showed significantly decreased WOMAC scores and Lequesne scores at 4, 12, 26 and 52 weeks after HA injections as compared with the baseline scores (all < 0.01). No significant difference was found between the two groups in WOMAC scores and Lequesne scores at 4 or 12 weeks after the injections (both >0.05). The WOMAC scores and Lequesne scores at 26 and 52 weeks after the injections were significantly higher in patellofemoral arthritis group than in CP group (both < 0.05). In both groups, the 30-m walking time and the stair ascending and descending time decreased significantly at 1, 2, 3, and 4 weeks after HA injections (all < 0.05) without significant differences between the two groups (all >0.05).@*CONCLUSIONS@#HA injection through the subpatellar route is effective for treatment of CP. HA injection produces better long-term efficacy for treatment of early CP than for advanced CP where patellofemoral arthritis occurs.

Chondromalacia Patellae , Follow-Up Studies , Humans , Hyaluronic Acid , Injections, Intra-Articular , Osteoarthritis, Knee , Pain Measurement , Prospective Studies , Severity of Illness Index , Treatment Outcome
Article in English | WPRIM | ID: wpr-759357


PURPOSE: Up to now, there is no feasible solution for stopping or reversing the degenerative process of osteoarthritis (OA). Our study evaluated the effect of intra-articular injection of growth hormone (GH) in OA-induced rabbit knees compared to hyaluronic acid (HA) and placebo. MATERIALS AND METHODS: A total of 21 male, skeletally mature, New Zealand rabbits received an intra-articular type II collagenase injection for OA induction. Two weeks later, the rabbits were randomized into three groups based on the weekly intra-articular injection to be received: GH, HA, and saline. Injections were done for three consecutive weeks. Evaluation was done at 8 weeks after treatment, clinically using the lameness period, macroscopically using the Yoshimi score and microscopically using the Mankin score. RESULTS: The shortest period of lameness was found in the GH group (15.9±2.12 days), compared to the HA group (19.4±1.72 days) and placebo group (25.0±2.94 days). There was a statistically significant difference in macroscopic scoring between groups (p=0.001) in favor of the GH group. There was also significant difference in the microscopic score between groups (p=0.001) also in favor of the GH group. CONCLUSIONS: Intra-articular injection of GH showed better clinical, macroscopic and microscopic results as compared to HA and placebo.

Collagenases , Growth Hormone , Human Growth Hormone , Humans , Hyaluronic Acid , Injections, Intra-Articular , Knee , Male , New Zealand , Osteoarthritis , Rabbits
Article in English | WPRIM | ID: wpr-772275


Collagen is the building component of temporomandibular joint (TMJ) discs and is often affected by inflammation in temporomandibular disorders. The macromechanical properties of collagen are deteriorated by chronic inflammation. However, the mechanism by which inflammation influences disc function remains unknown. The relationship between the ultrastructure and nanomechanical properties of collagen in inflamed discs should be clarified. Seven-week-old female Sprague-Dawley rats were randomly divided into two groups. Chronic TMJ inflammation was induced by intra-articular injection of complete Freund's adjuvant, and samples were harvested after 5 weeks. Picrosirius staining revealed multiple colours under polarized light, which represented alternative collagen bundles in inflamed discs. Using atomic force microscopy scanning, the magnitude of Young's modulus was reduced significantly accompanied with disordered collagen fibril arrangement with porous architecture of inflamed discs. Transmission electron microscopy scanning revealed a non-uniform distribution of collagen fibres, and oversized collagen fibrils were observed in inflamed discs. Fourier transform infrared microspectroscopy revealed a decrease in 1 338 cm/amide II area ratio of collagen in different regions. The peak positions of amide I and amide II bands were altered in inflamed discs, indicating collagen unfolding. Our results suggest that sustained inflammation deteriorates collagen structures, resulting in the deterioration of the ultrastructure and nanomechanical properties of rat TMJ discs.

Animals , Collagen , Female , Fibrillar Collagens , Freund's Adjuvant , Inflammation , Metabolism , Pathology , Injections, Intra-Articular , Random Allocation , Rats , Rats, Sprague-Dawley , Temporomandibular Joint , Temporomandibular Joint Disc , Temporomandibular Joint Disorders
Clinical Pain ; (2): 16-23, 2019.
Article in Korean | WPRIM | ID: wpr-785685


OBJECTIVE: To evaluate the effectiveness of dynamic balance exercise after intra-articular injection of hyaluronic acid (HA) therapy in elderly patients with unilateral knee osteoarthritis.METHOD: 30 patients with unilateral knee osteoarthritis were enrolled in this study. The patients were randomly divided into two groups: dynamic balance exercise after HA injection group (group A) and only HA injection group (group B). Both groups administered intra-articular HA injection and group A patients continued 20-session exercises for 4 weeks. The assessments were measured before injection and 4 weeks after treatment using the visual analog scale (VAS) for pain, the Western Ontario and McMaster University Osteoarthritis Index (WOMAC) for physical function, Berg balance scale (BBS), and computerized dynamic posturography using SMART Balance Master system for balance function.RESULTS: In both groups, significant improvements in VAS, WOMAC and balance function were observed. Compared between groups, group A showed significant improvements compared to group B in WOMAC and balance function.CONCLUSION: It is suggested that dynamic balance exercise may result in improved balance function and physical function in elderly patients with unilateral knee osteoarthritis.

Aged , Exercise , Humans , Hyaluronic Acid , Injections, Intra-Articular , Knee , Methods , Ontario , Osteoarthritis , Osteoarthritis, Knee , Rehabilitation , Visual Analog Scale